Monoamine Oxidase (MAO) Is Expressed at the Level of Mitral Valve with Severe Regurgitation in Hypertrophic Obstructive Cardiomyopathy: A Case Report
Hypertrophic obstructive cardiomyopathy (HOCM) is one of the most common hereditary heart diseases. The severely hypertrophied interventricular septum combined with the systolic anterior movement (SAM) of the mitral valve (MV) frequently cause a significant pressure gradient in the left ventricular...
Main Authors: | Ana Lascu, Raluca Șoșdean, Loredana Nicoleta Ionică, Alexandru S. Pescariu, Lucian Petrescu, Adina Ionac, Constantin T. Luca, Adrian Sturza, Horea B. Feier |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/58/12/1844 |
Similar Items
-
Prognostic Value of Mitral Regurgitation in Patients with Primary Hypertrophic Cardiomyopathy
by: Milorad Tesic, et al.
Published: (2023-10-01) -
β-Carboline Alkaloids in Soy Sauce and Inhibition of Monoamine Oxidase (MAO)
by: Tomás Herraiz
Published: (2023-03-01) -
Anesthesia management in patient with nonobstructive hypertrophic cardiomyopathy with severe mitral valvular regurgitation with severe pulmonary artery hypertension for mitral valve replacement: Its “walk a tight rope”
by: Nikhil N Mudgalkar
Published: (2021-01-01) -
The use of MitraClip for nonobstructive hypertrophic cardiomyopathy with mixed severe mitral valve regurgitation
by: Jie Zeng, et al.
Published: (2023-04-01) -
Catalysis & inhibition issues associated with Monoamine Oxidase (MAO). How unusually low α-C-H bond dissociation energies may open the door to single electron transfer
by: Jonathan Sánchez González, et al.
Published: (2023-12-01)